Understanding different types of Acute Lung Injury and ARDS in patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a structured clinical data and biosample platform for patients with Acute Lung Injury and Acute Respiratory Distress Syndrome (ARDS) in China. By analyzing the heterogeneity among these patients, the study seeks to develop clinical, physiological, and biological sub-phenotypes that can guide personalized treatment strategies. The research will involve collecting clinical data and biological samples from various provinces, utilizing mathematical and machine learning models to establish a classification system for the condition. The classification model will be validated using international databases and cohorts to ensure its reliability and applicability.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Meet the diagnostic criteria for Acute Respiratory Distress Syndrome (ARDS) according to the updated global definition in 2023.
* The patient or their legal representative signs an informed consent form.

Exclusion Criteria:

* Individuals aged less than 18 years old.
* Those who refuse to participate in the study.

Where it's running

• Jingen Xia
  Beijing, China Recruiting

Study contacts

• Study coordinator: Jingen Xia, M.D
• Email: 13466396561@163.com
• Phone: +8613466396561

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Assessing venous congestion in ARDS patients using ultrasound

  This study is testing if using ultrasound can help find out how common venous congestion is in patients with acute respiratory distress syndrome who are on mechanical ventilation.

  Recruiting Assistance Publique - Hôpitaux de Paris · Créteil, Val de Marne · NCT06805409

• IC14 (anti-CD14) treatment for hospitalized patients with ARDS

  This will test whether IC14, an antibody that blocks CD14, can improve oxygenation in adults hospitalized with ARDS who are on mechanical ventilation.

  Recruiting at 2 sites Phase 2 Implicit Bioscience · Seattle, Washington and 1 other locations · NCT06513949

• Prone positioning for infants with severe respiratory distress

  This study is testing if putting infants with severe breathing problems on their stomachs helps them breathe better after receiving treatment.

  Recruiting Medical University of Vienna · Vienna · NCT05002478

• Treating sepsis-related acute lung injury with gut microbiota transplantation

  The team will test whether transplanting healthy gut bacteria can help adults with sepsis-related acute lung injury or ARDS recover better.

  Recruiting Phase 2/3 Shanghai University of Traditional Chinese Medicine · Shanghai, Putuo · NCT07342205

• Understanding immune patterns and ECMO strategies to help adults with severe ARDS

  This study tests how different immune and clinical patterns in adults with moderate-to-severe ARDS respond to ECMO and lung-protective care, aiming to improve outcomes.

  Recruiting at 16 sites Southeast University, China · Beijing, Beijing Municipality and 38 other locations · NCT07726940

• Optimal corticosteroid dosing for ARDS: short vs. prolonged therapy

  This trial tests different corticosteroid doses and treatment lengths to see which helps adults with ARDS who are on ventilators.

  Recruiting Phase 4 National Taiwan University Hospital · Taipei · NCT07711964

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.